Pharmaceutical Manufacturing and Supply – Pentobarbital Sodium Injection

The contract pertains to the manufacture and supply of FDA-approved Pentobarbital Sodium Injection, a Schedule II controlled substance, under strict cGMP compliance standards. All production must include comprehensive batch testing and stability validation to ensure product safety, potency, and consistency, with full adherence to federal regulations governing controlled pharmaceuticals. The requirement is for a subcontract to fulfill the needs of the Department of Defense through the Medical Supply Chain Pharm FSA, with performance delivery directed to APO, ZIP 96260-5479. The solicitation, issued under NAICS code 325412 for pharmaceutical preparation manufacturing, is open for responses until July 27, 2026, and seeks qualified manufacturers capable of meeting the rigorous quality, security, and regulatory demands associated with controlled substance production and government distribution.